Practical perspectives on the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation: A view from the Middle East and North Africa.

J Saudi Heart Assoc · 2018 · PMC6000886 · PMID 29910583

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

[47] showed a trend toward higher rates of ischemic stroke and systemic embolism when low-dose apixaban (2.5 mg b.i.d.) was used compared with VKA in AF patients who were naïve to OAC treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.